Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase

Details for Australian Patent Application No. 2008319266 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Landry-Bayle, Adrienne M.; Gomez, Laurent; Epperson, Matthew T.; LeeDutra, Alice; Kearney, Aaron M.; Grice, Cheryl A.; Edwards, James P.; Eccles, Wendy; Mizradegan, Taraneh; Santillan Jr., Alejandro; Bacani, Genesis M.; Mcclure, Kelly J.; Bembenek, Scott D.

Agent Shelston IP

Pub. Number AU-A-2008319266

PCT Pub. Number WO2009/058347

Priority 60/984,126 31.10.07 US

Filing date 31 October 2008

Wipo publication date 7 May 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058347 Priority application(s): WO2009/058347

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008319267-Amide derivatives as sirtuin modulators

2008319265-Antibodies to GDF8 as uses thereof